Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.
Cristina Gonzalez-RoblesMichèle BartlettMatthew BurnellCaroline S ClarkeShlomi HaarMichele Tao-Ming HuBrook F R HuxfordAshwani JhaMichael LawtonAlastair J NoycePaola PicciniKuhan PushparatnamLynn RochesterCarroll SiuDaniel Johannes van WamelenCaroline H Williams-GrayMarie-Louise ZeisslerHenrik ZetterbergCamille B CarrollThomas FoltynieRimona Sharon WeilAnette-Eleonore Schragnull nullPublished in: Movement disorders : official journal of the Movement Disorder Society (2023)
The MDS-UPDRS Parts I + II sum score was chosen as the primary outcome for large 3-year disease-modification trials. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.